Gurusher Panjrath is a Cardiology physician affiliated with George Washington University Hospital. OpenAlex indexes 127 publications with 3,519 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2150 Pennsylvania Ave NW Ste 4407
Washington, DC 200373201
Telephone
202-741-2323Provider last certified this registry record 26 Oct 2021.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CVRx, Inc.Program year202554 payments$53,269openpaymentsdata.cms.gov ↗
- Alnylam Pharmaceuticals Inc.Program year202538 payments$47,033openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202518 payments$24,810openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.4%Beta blocker18.1%Metoprolol Succinate60%Carvedilol35%Labetalol Hcl5%Part D<11 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)14.7%Entresto100%Part D≥101 patients+ 14 more classes in this area
Metabolism & gastrointestinal
17.4%SGLT2 inhibitor15.1%Jardiance84%Farxiga17%Part D≥81 patientsGLP-1 receptor agonist1.8%Ozempic59%Trulicity41%Part D<11 patients+ 1 more class in this area
Blood & clotting
5.3%Factor Xa inhibitor4.5%Eliquis80%Xarelto20%Part D<11 patientsP2Y12 inhibitor0.8%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing
Journal of the American College of Cardiology
2025 - Nutrition and Front-of-Package Food Labeling as a Catalyst for Cardiovascular Health: 2025 ACC Concise Clinical Guidance
Journal of the American College of Cardiology
2025 - 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Catherine Bollard, MD
George Washington University Hospital
Roberta Debiasi, MD
George Washington University Hospital
Adelaide Robb, MD
George Washington University Hospital
Jonathan Reiner, MD
George Washington University Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”